BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 36342875)

  • 21. The Clinical Relevance of Psammoma Body and Hashimoto Thyroiditis in Papillary Thyroid Carcinoma: A Large Case-control Study.
    Cai YF; Wang QX; Ni CJ; Guo GL; Li Q; Wang OC; Wu L; Du HY; You J; Zhang XH
    Medicine (Baltimore); 2015 Nov; 94(44):e1881. PubMed ID: 26554782
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-4, IL-10 and high sensitivity-CRP as potential serum biomarkers of persistent/recurrent disease in papillary thyroid carcinoma with/without Hashimoto's thyroiditis.
    Stanciu AE; Serdarevic N; Hurduc AE; Stanciu MM
    Scand J Clin Lab Invest; 2015 Nov; 75(7):539-48. PubMed ID: 26305420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systemic immune-inflammation index: A new marker in differentiation of different thyroid diseases.
    Vural S; Muhtaroğlu A; Güngör M
    Medicine (Baltimore); 2023 Aug; 102(31):e34596. PubMed ID: 37543770
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Impact of Coexistent Hashimoto's Thyroiditis on Central Compartment Lymph Node Metastasis in Papillary Thyroid Carcinoma.
    Liu Y; Lv H; Zhang S; Shi B; Sun Y
    Front Endocrinol (Lausanne); 2021; 12():772071. PubMed ID: 34867817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Effects of Hashimoto Thyroiditis on Lymph Node Metastases in Unifocal and Multifocal Papillary Thyroid Carcinoma: A Retrospective Chinese Cohort Study.
    Zhu F; Shen YB; Li FQ; Fang Y; Hu L; Wu YJ
    Medicine (Baltimore); 2016 Feb; 95(6):e2674. PubMed ID: 26871795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnosis and surgical treatment of Hashimoto's thyroiditis complicated with papillary thyroid carcinoma (with 51 cases of clinical analysis)].
    Chen J; Wang J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2010 Mar; 24(6):257-60. PubMed ID: 20518289
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic value of antithyroid peroxidase antibody for incidental autoimmune thyroiditis based on histopathologic results.
    Rho MH; Kim DW; Hong HP; Park YM; Kwon MJ; Jung SJ; Kim YW; Kang T
    Endocrine; 2012 Dec; 42(3):647-52. PubMed ID: 22581205
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging trends and hot spots in autoimmune thyroiditis research from 2000 to 2022: A bibliometric analysis.
    Li Q; Yang W; Li J; Shan Z
    Front Immunol; 2022; 13():953465. PubMed ID: 36032148
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultrasound-based radiomics nomogram combined with clinical features for the prediction of central lymph node metastasis in papillary thyroid carcinoma patients with Hashimoto's thyroiditis.
    Jin P; Chen J; Dong Y; Zhang C; Chen Y; Zhang C; Qiu F; Zhang C; Huang P
    Front Endocrinol (Lausanne); 2022; 13():993564. PubMed ID: 36060946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of coexistent Hashimoto's thyroiditis on the extent of cervical lymph node dissection and prognosis in papillary thyroid carcinoma.
    Song E; Jeon MJ; Park S; Kim M; Oh HS; Song DE; Kim WG; Kim WB; Shong YK; Kim TY
    Clin Endocrinol (Oxf); 2018 Jan; 88(1):123-128. PubMed ID: 28906015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparative study of nuclear 8-hydroxyguanosine expression in Autoimmune Thyroid Diseases and Papillary Thyroid Carcinoma and its relationship with p53, Bcl-2 and Ki-67 cancer related proteins.
    Mseddi M; Ben Mansour R; Gouiia N; Mnif F; Bousselaa R; Abid M; Boudaouara T; Attia H; Lassoued S
    Adv Med Sci; 2017 Mar; 62(1):45-51. PubMed ID: 28187375
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary Thyroid Carcinoma Emerging from Hashimoto Thyroiditis Demonstrates Increased PD-L1 Expression, Which Persists with Metastasis.
    Lubin D; Baraban E; Lisby A; Jalali-Farahani S; Zhang P; Livolsi V
    Endocr Pathol; 2018 Dec; 29(4):317-323. PubMed ID: 30121940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Coexistence of differentiated thyroid carcinoma with primary thyroid lymphoma in a background of Hashimoto's thyroiditis.
    Vassilatou E; Economopoulos T; Tzanela M; Rontogianni D; Karakitsos P; Magou C; Hadjidakis D; Dimitriadis G
    J Clin Oncol; 2011 Sep; 29(25):e709-12. PubMed ID: 21747091
    [No Abstract]   [Full Text] [Related]  

  • 34. The Effects of Chronic Lymphocytic Thyroiditis on Clinicopathologic Factors in Papillary Thyroid Cancer.
    Sakiz D; Sencar ME; Calapkulu M; Ozturk Unsal I; Aktas L; Ucan B; Ozbek M; Cakal E
    Endocr Pract; 2021 Dec; 27(12):1199-1204. PubMed ID: 34293511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis.
    Lun Y; Wu X; Xia Q; Han Y; Zhang X; Liu Z; Wang F; Duan Z; Xin S; Zhang J
    Otolaryngol Head Neck Surg; 2013 Mar; 148(3):396-402. PubMed ID: 23300224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hashimoto's thyroiditis is associated with papillary thyroid carcinoma: role of TSH and of treatment with L-thyroxine.
    Fiore E; Rago T; Latrofa F; Provenzale MA; Piaggi P; Delitala A; Scutari M; Basolo F; Di Coscio G; Grasso L; Pinchera A; Vitti P
    Endocr Relat Cancer; 2011 Aug; 18(4):429-37. PubMed ID: 21565972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma.
    Loh KC; Greenspan FS; Dong F; Miller TR; Yeo PP
    J Clin Endocrinol Metab; 1999 Feb; 84(2):458-63. PubMed ID: 10022401
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does papillary thyroid carcinoma have a better prognosis with or without Hashimoto thyroiditis?
    Kwak HY; Chae BJ; Eom YH; Hong YR; Seo JB; Lee SH; Song BJ; Jung SS; Bae JS
    Int J Clin Oncol; 2015 Jun; 20(3):463-73. PubMed ID: 25312294
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Solid papillary thyroid carcinoma with Hashimoto's thyroiditis: description of a further case with challenging cytological features.
    Fulciniti F; Barizzi J; Trimboli P; Giovanella L
    BMJ Case Rep; 2019 Jan; 12(1):. PubMed ID: 30659000
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis.
    Mohamed SY; Ibrahim TR; Elbasateeny SS; Abdelaziz LA; Farouk S; Yassin MA; Embaby A
    Sci Rep; 2020 Jun; 10(1):10651. PubMed ID: 32606302
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.